Through the Microscope: Examining Modern Medicine

February 21, 2017

Medical breakthroughs, including new drug therapies and health technologies, have accelerated in recent years to transform patient care, turning formerly fatal diseases into chronic ones. These innovations are treating some of the rarest diseases and are bringing new tools to doctors and care providers.

The Atlantic explored the state of modern medicine and the science that has revolutionized treatments. We examined the role of personalized medicine and how new treatments can be made accessible to patients.

Watch full session videos

To view photos from this event, please visit our Facebook page

For more information, please contact Grace Harvey at

Presented by

Atlantic Live


  • Laurie Glimcher, MD
    Laurie Glimcher, MD President and CEO Dana-Farber Cancer Institute
  • Stephen J. Ubl
    Stephen J. Ubl President and CEO Pharmaceutical Research and Manufacturers of America
  • Tony Coles, MD
    Tony Coles, MD Chairman and CEO Yumanity Therapeutics
  • Gilmore O'Neill, MD
    Gilmore O'Neill, MD Senior Vice President, Late Stage Clinical Development Biogen Inc.
  • Noubar Afeyan, PhD
    Noubar Afeyan, PhD Founder, CEO and Senior Managing Partner Flagship Pioneering
  • Stephen Elledge, PhD
    Stephen Elledge, PhD Gregor Mendel Professor of Genetics and Medicine Harvard Medical School and the Division of Genetics at Brigham & Women’s Hospital
  • Dan Skovronsky, MD, PhD
    Dan Skovronsky, MD, PhD Senior Vice President, Clinical and Product Development Eli Lilly and Company
  • Joie Chen
    Joie Chen Contributor AtlanticLIVE
  • Ross Andersen
    Ross Andersen The Atlantic Senior Editor
  • Robert Green, MD, MPH
    Robert Green, MD, MPH Associate Physician, Brigham and Women's Hospital, Associate Professor of Medicine, Harvard Medical School and Director, Genomes2People Research Program
  • Lauren Stetson
    Lauren Stetson Participant of BabySeq Project
  • Joe Shortsleeve
    Joe Shortsleeve Former Chief Correspondent for WBZ-TV, Current Senior Advisor at Liberty Square
  • Julie Wolf-Rodda
    Julie Wolf-Rodda Director of Development Foundation for the National Institutes of Health


  • Tuesday, February 21
  • 8:30 a.m.WelcomeMargaret Low, President, AtlanticLIVE
  • 8:35 a.m.The DNA of Modern MedicineLaurie Glimcher, President and CEO, Dana-Farber Cancer Institute
    With Joie Chen, Contributor, AtlanticLIVE
  • 8:55 a.m.On the Frontlines of ScienceStephen Elledge, Gregor Mendel Professor of Genetics, Harvard Medical School and Division of Genetics, Brigham and Women’s Hospital
    Julie Wolf-Rodda, Director of Development, Foundation for the National Institutes of Health
    Daniel Skovronsky, Senior Vice President, Clinical and Product Development, Eli Lilly and Company
    With Ross Andersen, Senior Editor, The Atlantic
  • 9:35 a.m.Funding the Future Noubar Afeyan, CEO, Flagship Pioneering
    Tony Coles, CEO, Yumanity Therapeutics
    Gilmore O’Neill, Senior Vice President, Late Stage Clinical Development, Biogen
    With Joie Chen, AtlanticLIVE
  • 10:05 a.m.Making Medicine PersonalRobert Green, Co-Director, BabySeq Project, Brigham and Women’s Hospital and Harvard Medical School
    Lauren Stetson, Participant in BabySeq Project
    With Ross Andersen, The Atlantic
  • 10:35 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE


Also in This Series

Upcoming Events

  • Technology

    Franklin Foer In Conversation
    with Hanna Rosin

    Franklin Foer will join Hanna Rosin for a conversation about his new book World Without Mind and how consolidation of knowledge and information has changed how we contemplate the world.

  • Health Care

    Children and Cancer:
    An Atlantic Forum

    The Atlantic will break down the latest in immunotherapy and how it is being used to help young patients survive and thrive. And moving beyond anecdotal evidence, we'll examine how can big data can be used to track how pediatric cancers impact aspects of health for survivors down the road.

  • Health Care

    Cancer and the Community

    The Atlantic will explore challenges such as Nevada's shortage of doctors and specialists and learn what can be done from researchers, experts, stakeholders, survivors and patients living with cancer.